• OPEN AN ACCOUNT
Indian Indices
Sensex
76,059.77 -331.62
( -0.43%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,397.99 -2,024.61
(-3.05%)
Nikkei 225
10,738.51 99.34
(0.93%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
32.26
61.99
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

ntpc ltd
RHI Magnesita India reports consolidated net loss of Rs 518.11 crore in the March 2026 quarter
May 30,2026
Net loss of RHI Magnesita India reported to Rs 518.11 crore in the quarter ended March 2026 as against net profit of Rs 36.18 crore during the previous quarter ended March 2025. Sales rose 1.56% to Rs 932.26 crore in the quarter ended March 2026 as against Rs 917.97 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 382.94 crore in the year ended March 2026 as against net profit of Rs 202.51 crore during the previous year ended March 2025. Sales rose 9.40% to Rs 4019.95 crore in the year ended March 2026 as against Rs 3674.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales932.26917.97 2 4019.953674.50 9
OPM %9.3710.13 -10.9913.04 -
PBDT104.3884.49 24 433.49462.58 -6
PBT53.2137.83 41 236.47262.66 -10
NP-518.1136.18 PL -382.94202.51 PL